New Drugs4 min read
CagriSema: Novo Nordisk's 22.7% Weight Loss Drug Explained
CagriSema is Novo Nordisk's most ambitious new obesity drug. It combines two separate hormone targeting mechanisms in a single weekly injection and Phase 3 data shows it significan...
W
WeightEasy Editorial Team